Gabapentin Capsule
Product Images NDC 45963-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45963-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
The given text is a formula used to estimate the Glomerular Filtration Rate (GFR) for a patient. GFR is a measure of how well the kidneys are functioning. The formula calculates cLcr (creatinine clearance) value using the patient's age, weight, and serum creatinine level (which indicates how much creatinine is in their blood, another measure of kidney function). This formula is commonly used in clinical settings to monitor and assess kidney function in patients.*
FDA Label Image

1 (Image 10)

FDA Label Image

1 (Image 11)

FDA Label Image

1 (Image 12)

FDA Label Image

1 (Image 13)

1 (Image 13)
Gabapentin is a drug that comes in the form of capsules containing USP-indicated amounts of the active ingredient. The packaging includes a warning to keep this medication out of children's reach and to store it at a certain temperature. Patients are instructed to consult the accompanying circular for full dosing information. Additionally, the pharmacist should dispense the medication guide along with the drug. The medication is produced in India by Watson Pharma Private Limited, on behalf of Teva Pharmaceuticals in Parsippany, NJ. Details on serialization and lot/expiry dates are also provided.*
FDA Label Image

1 (Image 14)

1 (Image 14)
Gabapentin Capsules, USP is a prescription medication available in the form of capsules. Each capsule contains 300mg Gabapentin, USP. It is manufactured by Watson Pharma Private Limited in India and is distributed by Teva Pharmaceuticals in Parsippany, NJ. The medication should be stored in a tight, light-resistant container as defined by the USP and kept out of children's reach. A medication guide should be provided to the patient with each prescription. The dosage details can be found in the accompanying circular for full prescribing information. For any questions, call 1-888-838-2872. Lot/exp and serialization coding area details are also provided.*
FDA Label Image

1 (Image 15)

1 (Image 15)
This text describes a medication in the form of capsules with the active ingredient Gabapentin. It instructs pharmacists to dispense a Medication Guide to each patient and to keep the capsules in a tightly closed and light-resistant container. The usual dosage is detailed in an accompanying circular. The medication should be kept out of the reach of children and stored between 20° to 25°C. The medication was manufactured in India by Watson Pharma Private Limited and is distributed by Teva Pharmaceuticals. The text includes lot and expiration dates, a serialization coding area, and a contact number for questions.*
FDA Label Image

1 (Image 2)

FDA Label Image

1 (Image 3)

FDA Label Image

1 (Image 4)

FDA Label Image

1 (Image 5)

FDA Label Image

1 (Image 6)

1 (Image 6)
The text describes a chart showing the mean pain score for a study that has a dose titration period followed by a fixed dose period of 4 weeks. The study compares the effects of a placebo versus Gabapentin administered at a maximum dose of 3600 mg/day. The chart shows the mean pain score at baseline and over the course of the 4 weeks.*
FDA Label Image

2 (Image 7)

2 (Image 7)
This text includes information about a study that evaluated the effectiveness of Gabapentin in reducing pain. The study involved a fixed dose period of four weeks, during which participants were given either 1800mg or 2400mg of Gabapentin. The mean pain score was recorded and showed a value of zero. There is also information about the duration of the treatment period, which included both a titration period and a fixed dose period.*
FDA Label Image

3 (Image 8)

FDA Label Image

4 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.